Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value

Figure 1

Diagnosis of CRC utilizing circulating tumor nucleic acids. According to a robust, sensitive, and specific noninvasive screening associated with a panel of elevated ctDNA and ctRNA signature expression, it is conceivable that these blood biomarkers can be used for early CRC detection.